Showing 8,401 - 8,420 results of 10,824 for search 'significantly ((((lower decrease) OR (we decrease))) OR (((teer decrease) OR (mean decrease))))', query time: 0.52s Refine Results
  1. 8401

    Table 4_Therapeutic effects and mechanism analysis of Paeonia lactiflora extract (PLE) in menopausal rats with hot flashes.xlsx by Weilin Cui (21758462)

    Published 2025
    “…In addition, PLE had the effect of increasing the estradiol content and decreasing the luteinizing hormone content in the serum of rats, and the administration of 160 mg/kg of PLE also significantly increased the 5-hydroxytryptamine content in the serum of rats. …”
  2. 8402

    Table 1_Therapeutic effects and mechanism analysis of Paeonia lactiflora extract (PLE) in menopausal rats with hot flashes.xlsx by Weilin Cui (21758462)

    Published 2025
    “…In addition, PLE had the effect of increasing the estradiol content and decreasing the luteinizing hormone content in the serum of rats, and the administration of 160 mg/kg of PLE also significantly increased the 5-hydroxytryptamine content in the serum of rats. …”
  3. 8403

    Image 1_Therapeutic effects and mechanism analysis of Paeonia lactiflora extract (PLE) in menopausal rats with hot flashes.tif by Weilin Cui (21758462)

    Published 2025
    “…In addition, PLE had the effect of increasing the estradiol content and decreasing the luteinizing hormone content in the serum of rats, and the administration of 160 mg/kg of PLE also significantly increased the 5-hydroxytryptamine content in the serum of rats. …”
  4. 8404

    Table 3_Therapeutic effects and mechanism analysis of Paeonia lactiflora extract (PLE) in menopausal rats with hot flashes.xlsx by Weilin Cui (21758462)

    Published 2025
    “…In addition, PLE had the effect of increasing the estradiol content and decreasing the luteinizing hormone content in the serum of rats, and the administration of 160 mg/kg of PLE also significantly increased the 5-hydroxytryptamine content in the serum of rats. …”
  5. 8405

    Table 6_Therapeutic effects and mechanism analysis of Paeonia lactiflora extract (PLE) in menopausal rats with hot flashes.xlsx by Weilin Cui (21758462)

    Published 2025
    “…In addition, PLE had the effect of increasing the estradiol content and decreasing the luteinizing hormone content in the serum of rats, and the administration of 160 mg/kg of PLE also significantly increased the 5-hydroxytryptamine content in the serum of rats. …”
  6. 8406

    Table 5_Therapeutic effects and mechanism analysis of Paeonia lactiflora extract (PLE) in menopausal rats with hot flashes.xlsx by Weilin Cui (21758462)

    Published 2025
    “…In addition, PLE had the effect of increasing the estradiol content and decreasing the luteinizing hormone content in the serum of rats, and the administration of 160 mg/kg of PLE also significantly increased the 5-hydroxytryptamine content in the serum of rats. …”
  7. 8407

    Table 7_Therapeutic effects and mechanism analysis of Paeonia lactiflora extract (PLE) in menopausal rats with hot flashes.xlsx by Weilin Cui (21758462)

    Published 2025
    “…In addition, PLE had the effect of increasing the estradiol content and decreasing the luteinizing hormone content in the serum of rats, and the administration of 160 mg/kg of PLE also significantly increased the 5-hydroxytryptamine content in the serum of rats. …”
  8. 8408

    Data Sheet 1_Physical and biogeochemical processes in controlling the seasonal variation of dissolved oxygen in the Bohai and Yellow Seas.pdf by Wenshuo Zhang (164908)

    Published 2025
    “…Moreover, in this layer, photosynthesis, to some extent, regulates the [DO] and leads to the supersaturation in summer, whereas downward diffusion in autumn is mainly responsible for the gradually decreased saturation degree. The seasonal distribution of the [DO] in the bottom water is similar with that in the surface water, with much lower [DO] and significant undersaturation in summer in the BS and in summer and autumn in the YS. …”
  9. 8409

    Image 3_Tetramethylpyrazine attenuates the blood-brain barrier damage against ischemic stroke by targeting endothelin-1/Akt pathway in astrocytes.tif by Minzhen Deng (11267109)

    Published 2025
    “…In the MCAO animal model, TMP improved neurological scores, decreased infarct size, and lowered ET-1 levels, thus strengthening the blood-brain barrier and reducing oxidative stress. …”
  10. 8410

    Image 2_Tetramethylpyrazine attenuates the blood-brain barrier damage against ischemic stroke by targeting endothelin-1/Akt pathway in astrocytes.tif by Minzhen Deng (11267109)

    Published 2025
    “…In the MCAO animal model, TMP improved neurological scores, decreased infarct size, and lowered ET-1 levels, thus strengthening the blood-brain barrier and reducing oxidative stress. …”
  11. 8411

    Image 1_Tetramethylpyrazine attenuates the blood-brain barrier damage against ischemic stroke by targeting endothelin-1/Akt pathway in astrocytes.tif by Minzhen Deng (11267109)

    Published 2025
    “…In the MCAO animal model, TMP improved neurological scores, decreased infarct size, and lowered ET-1 levels, thus strengthening the blood-brain barrier and reducing oxidative stress. …”
  12. 8412

    Application of yeast-based biocontrol agents against fruit spoilage moulds by Zukisani Gomomo (20853371)

    Published 2025
    “…The study concludes that the selected non-<i>Saccharomyces</i> yeasts hold significant potential as biological control agents against fruit spoilage moulds. …”
  13. 8413

    Source data.xlsx by Qian Cheng (20991434)

    Published 2025
    “…This limitation restricts electrode thickness, decreases power density, and shortens battery lifetime. …”
  14. 8414

    FLEXI interactions with RNA-binding proteins. by Jun Yao (9646)

    Published 2024
    “…Lower GC%, percentage of RBPs whose binding sites were significantly enriched in FLEXIs having lower GC% content than other FLEXIs (density plots, <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1011416#pgen.1011416.s016" target="_blank">S16 Fig</a>); phastCons scores ≥0.75, RBPs whose binding sites were significantly enriched in evolutionarily conserved FLEXIs with phastCons ≥0.75 (<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1011416#pgen.1011416.g003" target="_blank">Fig 3C</a>). …”
  15. 8415

    Flexible Microfluidic Devices for Tunable Formation of Double Emulsion by Uditha Roshan (20841937)

    Published 2025
    “…We demonstrated that stretching increases the core size and shell thickness and decreases the generation frequency. …”
  16. 8416

    Flexible Microfluidic Devices for Tunable Formation of Double Emulsion by Uditha Roshan (20841937)

    Published 2025
    “…We demonstrated that stretching increases the core size and shell thickness and decreases the generation frequency. …”
  17. 8417
  18. 8418

    Image 2_Establishment and validation of survival nomogram score staging for esophageal squamous cell carcinoma patients after minimally invasive surgery combined with immune progno... by Shao-jun Xu (11633956)

    Published 2025
    “…The t-AUC and DCA demonstrated that the nomograms had a better predictive value and clinical benefit rate than the American Joint Committee on Cancer (AJCC) staging. Accordingly, we developed the SNS staging and found that the OS and DFS were significantly different among patients at different stages (all P < 0.001). …”
  19. 8419

    Flexible Microfluidic Devices for Tunable Formation of Double Emulsion by Uditha Roshan (20841937)

    Published 2025
    “…We demonstrated that stretching increases the core size and shell thickness and decreases the generation frequency. …”
  20. 8420

    Image 1_Establishment and validation of survival nomogram score staging for esophageal squamous cell carcinoma patients after minimally invasive surgery combined with immune progno... by Shao-jun Xu (11633956)

    Published 2025
    “…The t-AUC and DCA demonstrated that the nomograms had a better predictive value and clinical benefit rate than the American Joint Committee on Cancer (AJCC) staging. Accordingly, we developed the SNS staging and found that the OS and DFS were significantly different among patients at different stages (all P < 0.001). …”